Novartis Investigative Site

Fort Mill, South Carolina 29707

0 studies enrolling now · 7 studies all time

What they study most

Acute Gouty Arthritis, Atherosclerosis, Cardiovascular Disease and Lipoprotein(a), Chronic Heart Failure (CHF), Chronic Obstructive Pulmonary Disease

Studies at this site

• Assessing the Impact of Lipoprotein (a) Lowering With Pelacarsen (TQJ230) on Major Cardiovascular Events in Patients With CVD — Running, not enrolling
• Efficacy and Safety of LCZ696 Compared to Valsartan on Cognitive Function in Patients With Chronic Heart Failure and Preserved Ejection Fraction — Completed
• Lipoprotein(a) in Patients With Cardiovascular Disease (CVD) — Completed
• Long-Term Safety and Tolerability of Canakinumab Prefilled Syringes in Frequently Flaring Acute Gouty Arthritis Patients — Completed
• Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events) — Completed
• Efficacy and Safety Study of Indacaterol Maleate/Glycopyrronium Bromide in Chronic Obstructive Pulmonary Disease (COPD) Patients. — Completed
• NVA237 BID Versus Placebo Twelve-week Efficacy Study — Completed